Can You Take Mounjaro If You Have Hypothyroidism?

The decision you are actually facing

If you have hypothyroidism and are considering Mounjaro, the question is not quite as simple as yes or no. Most people asking this have a diagnosis of autoimmune hypothyroidism (Hashimoto's thyroiditis is the most common cause in the UK), are taking levothyroxine daily, and have TSH levels that sit comfortably in range. For that group, the situation is very different from someone whose thyroid disease is newly diagnosed, under-treated, or complicated by other endocrine conditions. Framing it as a single decision is why a clinical consultation matters.

You may be frustrated. Perhaps your GP said Mounjaro is not available on the NHS for you yet, or you have looked online and found conflicting answers. That frustration is understandable, and it is why getting a clear, properly reviewed answer is worth doing properly rather than quickly. Our detailed page on Mounjaro and hypothyroidism goes deeper into the clinical picture; what follows here covers the key factors a prescriber weighs.

What the prescribing information does (and does not) say

Hypothyroidism is not listed as a contraindication to tirzepatide in the UK Summary of Product Characteristics. The contraindication that does apply relates to a personal or family history of medullary thyroid carcinoma or MEN2, a rare hereditary cancer syndrome that affects the thyroid but is entirely separate from the common underactive thyroid most people mean when they say hypothyroidism. This distinction matters enormously and is the reason people with hypothyroidism are not automatically excluded.

What is less settled is the interaction with levothyroxine absorption. Tirzepatide slows gastric emptying, one of the mechanisms behind its appetite-reducing effect. Levothyroxine is a medicine whose absorption is sensitive to timing, food, and gastric conditions. There is no specific published study examining levothyroxine pharmacokinetics alongside tirzepatide, but the principle that slowed gastric emptying could affect absorption is well-recognised for GLP-1-class medicines more broadly. This does not mean you cannot take them together; it means thyroid function should be monitored after starting treatment and after dose increases. The BNF entry for tirzepatide and the medicine's patient information leaflet are the definitive references for interactions, and our prescribers check these at every review.

The levothyroxine timing question

Levothyroxine is typically taken first thing in the morning, on an empty stomach, 30 to 60 minutes before food, a routine most people with hypothyroidism know well. If tirzepatide slows gut motility, the concern is that the levothyroxine may sit in the stomach longer than usual before reaching the small intestine where it is absorbed. In practice, the clinical advice from endocrinologists tends to be: keep the levothyroxine routine unchanged, and plan for a TSH check around six to eight weeks after starting Mounjaro or after any significant dose adjustment. If TSH drifts, the levothyroxine dose can be recalibrated. This is a manageable clinical situation, not a reason to avoid treatment, but it does mean your prescriber, your GP, and ideally your endocrinologist if you have one, should be joined up. If you also have type 2 diabetes alongside your thyroid condition, the picture is more involved still, and shared care across your clinical team becomes even more important.

Significant weight loss, if it occurs, independently affects thyroid hormone requirements. This is true of any weight-loss intervention and is not a Mounjaro-specific risk, but it is a reason for planned monitoring rather than a reason to stay at a higher weight. The NHS England guidance on weight management injections reinforces the importance of medical oversight throughout treatment, which is exactly the aftercare model our prescribers apply.

Who makes the final call, and how

A prescriber reviewing your case for Mounjaro will want to know: Is your hypothyroidism diagnosed and treated? Is your TSH stable? Are you on a fixed levothyroxine dose, or has it changed frequently? Do you have any thyroid nodules, and has anyone raised MTC or MEN2 in your family history? These are the questions that shape the clinical decision, not a blanket rule about thyroid disease. Explore broader thyroid considerations with Mounjaro or read about the overactive thyroid picture if that is more relevant to you.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not automated screening. They will ask about your thyroid history specifically, review your current medicines, and make a considered decision. If your case warrants input from your GP or endocrinologist first, they will say so. That straightforward clinical honesty is the service. You can also read about how Mounjaro works more broadly, or check the treatment overview to see the full picture of what is available. For a wider view of related health conditions, our page on Mounjaro and fatty liver covers another common comorbidity in a similar framework. If you have questions before starting a consultation, our FAQs are a useful first stop.